View of CRISPR-dCas9-Mediated Epigenetic Reactivation of LRIG1 Suppresses Oncogenic Signaling in Triple-Negative Breast Cancer

Return to Article Details CRISPR-dCas9-Mediated Epigenetic Reactivation of LRIG1 Suppresses Oncogenic Signaling in Triple-Negative Breast Cancer Download Download PDF